National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

medroxyprogesterone
A synthetic derivative of progesterone administered as an acetate salt (medroxyprogesterone acetate) with antiestrogenic activity. As a do all progestins, medroxyprogesterone binds to and activates nuclear receptors which subsequently bind to and activate target genes for transcription. As an antiestrogen, this agent may inhibit the growth-stimulating effects of estrogen on estrogen-sensitive tumor cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:medroxyprogesterone acetate
US brand names:Curretab
Depo-Provera
Provera
Provera Dosepak
Abbreviation:MPA
Chemical structure names:
  • (6alpha)-17-hydroxy-6-methylpregn-4-ene-3,20-dione
  • 17alpha-hydroxy-6alpha-methylprogesterone
  • 6alpha-methyl-17alpha-hydroxyprogesterone
  • 6alpha-methyl-4-pregnen-17alpha-ol-3,20-dione



Previous:mechlorethamine hydrochloride, Meclan, meclocycline sulfosalicylate, Medlone 21, Medrol
Next:Megace, megestrol acetate, MEK inhibitor AZD8330, MEK inhibitor GSK1120212, MEK inhibitor RDEA119

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov